Diabetes and cardiometabolic companies often sell to payers, employers, and providers as much as they do to patients. We create a demand engine that builds qualified pipeline across these buyers – using content and channels that meet the category's standards for credibility and compliance.
The Challenge
The buyer is frequently a payer or employer, rather than the patient
Many cardiometabolic companies are paid by health plans, employers, or providers, yet run demand gen aimed only at patients. That leaves the actual budget-holders untouched by any pipeline motion. Generating demand from payers and employers requires different content, channels, and proof than patient acquisition, and skipping it caps growth at whatever patients will self-pay.
Long, committee-led sales cycles stall without a nurtured pipeline
A health plan or large employer takes months and multiple stakeholders to decide, so a demand engine that generates a burst of interest and no nurture lets that interest go cold. Without content and touchpoints that keep the company credible across a long evaluation, pipeline stalls. Demand gen here is a sustained program, not a campaign that ends when the lead arrives.
Clinical and economic evidence gates every serious conversation
Payers and employers want evidence of clinical outcomes and cost savings before they engage seriously, so demand content that leads with features falls flat. Teams without outcome and health-economic proof struggle to generate anything past a first meeting. Building demand around the evidence these buyers actually evaluate is what turns interest into qualified pipeline.
Compliance restricts the demand tactics most B2B teams rely on
The aggressive claims and broad targeting common in B2B demand gen create regulatory exposure in a health category, and content that overstates outcomes damages credibility with sophisticated buyers. Teams that ignore this either get flagged or lose trust. Demand gen has to be built to be compelling and defensible at the same time, which most B2B playbooks are not.
How We Help
We begin by identifying the true buyers – patients, certainly, but also the payers, employers, and providers who control the budget – then creating a demand strategy for each, connected to the [growth strategy](/services/strategy/). This keeps the engine from building patient interest while leaving the people who actually pay unreached.
We shape demand around the proof each buyer considers. For payers and employers, that means clinical outcome and health-economic content, credibility signals, and the evidence required for serious conversations, created through our [marketing](/services/marketing/) practice so demand content is persuasive and defensible at the same time.
We build for a long, committee-driven cycle. Instead of a short campaign burst, we create sustained nurture – content, touchpoints, and channels that maintain the company's credibility throughout a multi-month evaluation – allowing interest to develop into qualified pipeline rather than turn cold. Nurture is the engine's foundation, not an afterthought.
We select channels that suit both the buyer and the rules. Based on the audience, that may include industry events, provider networks, targeted account programs, and compliant content channels, generating demand where these buyers already operate without creating the exposure associated with aggressive tactics.
Through our [measurement](/services/measurement/) practice, we instrument the engine by connecting demand activity to qualified pipeline and closed relationships by buyer type. This concentrates investment on the segments and channels that deliver real deals. Demand that fails to convert into pipeline is cut rather than scaled.
We do not run a patient-only campaign and label it demand gen. We create a multi-buyer demand engine that builds qualified pipeline among the people who actually make the decisions.
What we deliver
- A demand strategy segmented by patient, payer, employer, and provider buyers
- Clinical outcome and health-economic content that gates serious conversations
- A sustained nurture program built for long, committee-driven cycles
- Channels matched to each buyer without triggering compliance exposure
- Compliant, credible demand content that avoids overstated claims
- Measurement tying demand activity to qualified pipeline by buyer type
In diabetes and cardiometabolic health, demand generation focused solely on patients limits growth to what patients can self-pay, since the payers and employers who actually control the budget assess clinical and economic proof through a long, committee-driven cycle that patient-only campaigns never reach.
Our Methodology
Our 90-day sprint creates a multi-buyer demand engine instead of a patient campaign. Days 1-30 center on strategy: we determine the real buyers for your model, map the evidence each evaluates, and define the channels and nurture needed for the long cycle. This phase concludes with a segmented demand strategy and content plan.
During days 31-60, we build the engine. We create the clinical and economic proof content required by payers and employers, establish compliant channels suited to each buyer, and develop the nurture program that sustains company credibility across a months-long evaluation. Every element is designed to be persuasive and defensible at once.
Days 61-90 cover launch, measurement, and handoff. We operate the engine, connect activity to qualified pipeline by buyer type, focus investment on the segments generating deals, and document the playbook for your team to run. Since pipeline develops slowly in this category, the sprint establishes a sustained program and the measurement needed to guide it, rather than a one-off lead burst.
How We Work
During the first 30 days, we collaborate with your growth, clinical, and commercial leads because identifying buyers and gathering the evidence they assess demands input from all three. Expect working sessions covering buyer segmentation, proof content, and sales-cycle realities.
Days 30-60 shift into the build. Rather than simply activating ads, we create outcome and economic content, establish compliant channels for each buyer, and build the nurture program for the long cycle, with everything instrumented to pipeline.
Days 60-90 focus on operation and handoff. We run the engine, evaluate demand against qualified pipeline by buyer type, redirect investment toward what generates deals, and transfer the playbook. Since committee-driven cycles span months, most engagements run 5-6 months, allowing us to watch interest develop into real pipeline.
The team consists of a demand strategist responsible for segmentation and program design, a content resource creating clinical and economic proof, and a measurement resource connecting activity to pipeline, scaled according to the number of buyer segments involved.
- Qualified pipeline from payers and employers, not only patients
- Demand built around the clinical and economic proof buyers evaluate
- Sustained nurture that survives long, committee-driven cycles
- Compliant channels that avoid regulatory exposure
- Investment concentrated on segments that produce real deals
If your diabetes & cardiometabolic health company needs demand generation leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a demand generation engagement cost for a diabetes or cardiometabolic business?
A demand program generally costs $15K-$35K/month, based on the number of buyer segments we support and the amount of proof content and nurture required by the long cycle, excluding media and event spend. Pricing increases with the number of segments and channels, rather than being tied to a fixed lead target. Since we measure qualified pipeline instead of raw leads, investment is evaluated against deals generated, not cost-per-lead.
Why does demand gen differ for cardiometabolic companies compared with typical B2B?
The actual buyers are frequently payers, employers, and providers who assess clinical outcomes and cost savings through a long, committee-driven cycle, while the aggressive claims typical of B2B demand gen introduce regulatory exposure in this category. As a result, the proof, channels, and nurture must all be designed differently. We build demand around the evidence these buyers assess and within the category's compliance boundaries.
How do you build demand among payers and employers, rather than only patients?
We create content based on the clinical outcome and health-economic proof these buyers assess, use the channels where they already operate, including industry events and targeted account programs, and nurture them throughout the lengthy evaluation. Patient demand and payer demand are managed as distinct motions, each with separate content and channels. This is how we reach the people who actually control the budget.
How long does demand gen take to generate pipeline in this category?
Initial engagement signals emerge within weeks, but qualified pipeline from payers and employers develops over months because their buying cycles are lengthy and committee-driven. We instrument for pipeline from day one, letting you track how interest progresses instead of relying solely on closed deals. That is why the program emphasizes sustained nurture rather than a brief campaign.
How do you make demand content persuasive while keeping it compliant?
We design proof content to be evidence-backed and defensible – using real outcomes and economics instead of exaggerated claims – which is also what sophisticated payer and employer buyers value. Claims review happens during content creation, rather than serving as a gate that strips its impact. The outcome is demand content that remains compelling and safe, without sacrificing one for the other.
What does the process of getting started with demand gen involve?
We begin by determining the real buyers for your model, mapping the evidence each evaluates, and identifying the channels and nurture necessary for the long cycle. This delivers a segmented demand strategy and content plan before any building begins. If your diabetes or cardiometabolic company creates patient interest but lacks payer or employer pipeline, we should talk.
